Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9657 | 1067 | 36.6 | 80% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
669 | 12548 | PSORIASIS//PSORIATIC ARTHRITIS//CALCIPOTRIOL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | UNIT MULTIDISCIPLINARY INVEST BIOMED | Address | 5 | 55% | 1% | 6 |
2 | PSORIATIC NEPHROPATHY | Author keyword | 3 | 100% | 0% | 3 |
3 | DERMATOL VENEREOL PAEDIAT DERMATOL | Address | 2 | 36% | 0% | 5 |
4 | EPIDEMIOL PUBL HEALING | Address | 2 | 67% | 0% | 2 |
5 | HLTH PLANNING POLICY WING | Address | 2 | 50% | 0% | 3 |
6 | HOSP UNIV AMBROISE PARE | Address | 2 | 50% | 0% | 3 |
7 | MURDOUGH FAMILY PSORIASIS | Address | 2 | 22% | 1% | 8 |
8 | PSORIASIS | Address | 2 | 17% | 1% | 10 |
9 | DANISH PUBL HLTH | Address | 2 | 43% | 0% | 3 |
10 | DERMATOL DANIELE INNOCENZI | Address | 2 | 43% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PSORIATIC NEPHROPATHY | 3 | 100% | 0% | 3 | Search PSORIATIC+NEPHROPATHY | Search PSORIATIC+NEPHROPATHY |
2 | PSORIASIS SEVERITY | 2 | 43% | 0% | 3 | Search PSORIASIS+SEVERITY | Search PSORIASIS+SEVERITY |
3 | PSORIASIS COMORBIDITY | 1 | 100% | 0% | 2 | Search PSORIASIS++COMORBIDITY | Search PSORIASIS++COMORBIDITY |
4 | PSORIASIS GUIDELINES | 1 | 100% | 0% | 2 | Search PSORIASIS+GUIDELINES | Search PSORIASIS+GUIDELINES |
5 | TUMOR NECROSIS FACTOR ALFA INHIBITOR | 1 | 100% | 0% | 2 | Search TUMOR+NECROSIS+FACTOR+ALFA+INHIBITOR | Search TUMOR+NECROSIS+FACTOR+ALFA+INHIBITOR |
6 | CHRONIC PLAQUE PSORIASIS | 1 | 17% | 1% | 6 | Search CHRONIC+PLAQUE+PSORIASIS | Search CHRONIC+PLAQUE+PSORIASIS |
7 | STNF R1 | 1 | 21% | 0% | 3 | Search STNF+R1 | Search STNF+R1 |
8 | PASI SCORE | 1 | 16% | 0% | 4 | Search PASI+SCORE | Search PASI+SCORE |
9 | 7 DAY FOOD RECORDS | 1 | 50% | 0% | 1 | Search 7+DAY+FOOD+RECORDS | Search 7+DAY+FOOD+RECORDS |
10 | 99MTC MIBI SPECT | 1 | 50% | 0% | 1 | Search 99MTC+MIBI+SPECT | Search 99MTC+MIBI+SPECT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VASCULAR DISEASES | 33 | 43% | 5% | 58 |
2 | ATHEROSCLEROSIS RISK FACTORS | 8 | 45% | 1% | 14 |
3 | PLAQUE PSORIASIS | 7 | 12% | 6% | 60 |
4 | FOLIC ACID LEVELS | 4 | 67% | 0% | 4 |
5 | EVIDENT CARDIOVASCULAR DISEASE | 4 | 21% | 2% | 17 |
6 | OCCLUSIVE VASCULAR DISEASE | 4 | 38% | 1% | 8 |
7 | ITALIAN CASE CONTROL | 3 | 22% | 1% | 10 |
8 | IMPAIRED ENDOTHELIAL FUNCTION | 2 | 24% | 1% | 9 |
9 | ETIOPATHOGENETIC FACTOR | 1 | 100% | 0% | 2 |
10 | INCIDENT PSORIASIS | 1 | 100% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence | 2013 | 142 | 52 | 48% |
Psoriasis and the Risk of Diabetes Mellitus A Systematic Review and Meta-analysis | 2013 | 36 | 39 | 79% |
Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Observational Studies | 2013 | 33 | 41 | 76% |
Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies | 2013 | 48 | 36 | 53% |
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review | 2013 | 29 | 57 | 79% |
Incidence of Cardiovascular Disease in Individuals with Psoriasis: A Systematic Review and Meta-Analysis | 2013 | 33 | 34 | 68% |
Cardiovascular Risk and Psoriasis: Beyond the Traditional Risk Factors | 2014 | 14 | 53 | 57% |
The association between psoriasis and hypertension: a systematic reviewandmeta-analysis of observational studies | 2013 | 27 | 40 | 78% |
The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies | 2012 | 55 | 37 | 62% |
Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis | 2015 | 2 | 39 | 51% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNIT MULTIDISCIPLINARY INVEST BIOMED | 5 | 55% | 0.6% | 6 |
2 | DERMATOL VENEREOL PAEDIAT DERMATOL | 2 | 36% | 0.5% | 5 |
3 | EPIDEMIOL PUBL HEALING | 2 | 67% | 0.2% | 2 |
4 | HLTH PLANNING POLICY WING | 2 | 50% | 0.3% | 3 |
5 | HOSP UNIV AMBROISE PARE | 2 | 50% | 0.3% | 3 |
6 | MURDOUGH FAMILY PSORIASIS | 2 | 22% | 0.7% | 8 |
7 | PSORIASIS | 2 | 17% | 0.9% | 10 |
8 | DANISH PUBL HLTH | 2 | 43% | 0.3% | 3 |
9 | DERMATOL DANIELE INNOCENZI | 2 | 43% | 0.3% | 3 |
10 | SECT INFLAMMAT CARDIOMETAB DIS | 2 | 43% | 0.3% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000289218 | PSORIASIS//EFALIZUMAB//ALEFACEPT |
2 | 0.0000209481 | PSORIATIC ARTHRITIS//PSORIAT ARTHRIT PROGRAM//PROGNOSIS STUDIES RHEUMAT DIS |
3 | 0.0000175585 | CHILDHOOD PSORIASIS//JUVENILE PSORIASIS//PERIANAL STREPTOCOCCAL DERMATITIS |
4 | 0.0000148109 | PSORIASIS//TAIYUAN CITY HOSP//MOUSE TAIL TEST |
5 | 0.0000121829 | APPARENT REDOX POTENTIAL//ERYTHROCYTE NA K ATPASE//DEMETHYLDIISOEUGENOL |
6 | 0.0000116275 | ANTI TNF ALPHA ANTIBODY INFLIXIMAB//EPIDEMIOL COMPUTAT BIOL//RHEUMATOID CACHEXIA |
7 | 0.0000081008 | DGLA//DIHOMO GAMMA LINOLENIC ACID//EVENING PRIMROSE OIL |
8 | 0.0000059924 | PSO P27//PSORIASIS PUSTULOSA PALMARIS ET PLANTARIS//ANTI DOUBLE STRANDED DEOXYRIBONUCLEIC ACID |
9 | 0.0000058607 | FUMARIC ACID ESTERS//DIMETHYL FUMARATE//DIMETHYLFUMARATE |
10 | 0.0000057058 | SERV ONCOL SPERIMENTALE C//CORNEA DEPOSITS//IMMUNOLOGICAL DISTURBANCE |